Endo USA, Inc.

Malvern, PA Professional servicesNAICS 541700

Self-funded health planPlan year 2025Renews January
1,194Participants0% vs. prior year
$2.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#20 of 37Professional services in PABy participants

Overview

Endo USA, Inc. sponsors a self-funded health plan that covered 1,194 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,194 · prior year 1,194
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Endo USA, Inc. Flexible Benefit Plan, plan 501 (1,194 participants)
Broker compensation
$167K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Life Insurance Company of North AmericaLife, Long-term disability328$1.6M$96K
Reliastar Life Insurance CompanyAccident, Critical Illness, Hospital712$191K$48K
Vision Service PlanVision1,023$129K—
Transamerica Life Insurance CompanyLife135$76K$14K
MetLife Legal PlansLegal149$27K$3K
Federal Insurance CompanyBusiness Travel Accident328$20K$5K
Aetna Behavioral Health, LLCEmployee Assistance Program328$14K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$2.8M/ year

Estimated prescription spend: 1,194 participants × $2,371 national average per member. Usually higher once dependents are counted.

$74K–$181K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$22K–$54K
Lower-cost therapeutic alternatives$31K–$66K
Generic pricing vs. actual cost$14K–$41K
PBM contract terms$7K–$21K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Endo USA, Inc.
Sponsor EIN
93-4789629
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 93-4789629 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Endo USA, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Endo USA, Inc..

Request a correction · Methodology